CIM
Calvert Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-4,617
| Closed | -$313K | – | 800 |
|
|
2016
Q3 | $313K | Buy |
4,617
+304
| +7% | +$20.6K | 0.01% | 642 |
|
|
2016
Q2 | $239K | Buy |
4,313
+36
| +0.8% | +$2K | 0.01% | 684 |
|
|
2016
Q1 | $268K | Buy |
4,277
+698
| +20% | +$43.7K | 0.01% | 633 |
|
|
2015
Q4 | $337K | Buy |
3,579
+612
| +21% | +$57.6K | 0.02% | 537 |
|
|
2015
Q3 | $238K | Buy |
2,967
+119
| +4% | +$9.55K | 0.01% | 534 |
|
|
2015
Q2 | $341K | Sell |
2,848
-294
| -9% | -$35.2K | 0.02% | 464 |
|
|
2015
Q1 | $328K | Buy |
3,142
+692
| +28% | +$72.2K | 0.02% | 476 |
|
|
2014
Q4 | $238K | Buy |
+2,450
| New | +$238K | 0.02% | 519 |
|